Prevention of Hernia After Loop Ileostomy Reversal (PHaLIR)
Primary Purpose
Loop Ileostomy
Status
Recruiting
Phase
Phase 2
Locations
Sweden
Study Type
Interventional
Intervention
Mesh reinforcement
No reinforcement
Sponsored by
About this trial
This is an interventional treatment trial for Loop Ileostomy
Eligibility Criteria
Inclusion Criteria:
- Patients operated for low anterior resection for rectal cancer with a diverting loop ileostomy and planned for stoma reversal
Exclusion Criteria:
- Language barrier or cognitive disability
- Recurrent cancer
Sites / Locations
- Stockholm South General HospitalRecruiting
- Ersta HospitalRecruiting
- Södertälje HospitalRecruiting
- Västmanland HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Placebo Comparator
Arm Label
Mesh reinforcement
No reinforcement
Arm Description
Retro muscular mesh at the stoma site.
Standard closure of the abdominal wall
Outcomes
Primary Outcome Measures
Hernia
Hernia at the site of the stomal closure
Secondary Outcome Measures
Operation time
Total operation time
Time for closing the stoma site
Time required to close the stoma site
Hospital stay
Days to discharge
Postoperative pain
Pain assessed on a Visual analogue scale ranging from 0 to 100, without subscales. 0 corresponds to no pain and 100 the most intense pain sensation imaginable.
Postoperative complications
Complications, including surgical site infections
Full Information
NCT ID
NCT03720262
First Posted
October 24, 2018
Last Updated
February 14, 2023
Sponsor
Karolinska Institutet
Collaborators
Stockholm South General Hospital
1. Study Identification
Unique Protocol Identification Number
NCT03720262
Brief Title
Prevention of Hernia After Loop Ileostomy Reversal
Acronym
PHaLIR
Official Title
Prevention of Hernia After Loop Ileostomy Reversal
Study Type
Interventional
2. Study Status
Record Verification Date
February 2023
Overall Recruitment Status
Recruiting
Study Start Date
March 1, 2018 (Actual)
Primary Completion Date
December 31, 2026 (Anticipated)
Study Completion Date
December 31, 2029 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Karolinska Institutet
Collaborators
Stockholm South General Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
PHaLIR is a prospective, double-blinded randomized study in which patients planned for stoma reversal after rectal cancer surgery are randomized between retro muscular mesh Ultrapro Advanced or standard treatment without mesh.
Detailed Description
A temporary loop ileostomy is widely used when operating rectal cancer. The ostomy is then reversed in a separate operation. Morbidity of stoma reversal is significant, but not clearly defined. One complication in connection with stoma closure is development of hernia at the former stoma site.
A hernia is a weakening of the muscular layers and the connective tissue of the abdominal wall, which may cause pain and discomfort, as well as an inconvenient bulge. A hernia could also cause more serious complication of obstructed or strangulated bowel. According to international studies, the incidence of hernia at the ostomy site varies between 7% and 35%. Many of the studies are heterogenic and some of them include both colostomies and ileostomies. Among studies that focus on reversal of ileotomies the hernia incidence varies between 11-15%. Preliminary results from a retrospective study in Stockholm indicates a frequency of 7,9%.
The best method to avoid hernia after stoma closure is not known. Most commonly surgeons tend to close the fascia in one layer with monofilament suture. In the study mentioned above 91% of the operations were done with one-layer monofilament, mostly PDS. Use of prophylactic mesh in the abdominal wall has been proposed, but there is currently insufficient scientific evidence to recommend it as a routine.
The present study is focused on loop ileostomy closure after rectal cancer. A non-heterogenous group of ostomies will serve as a base to evaluate whether the incidence of hernia may be reduced. If this study detects a decreased frequency of hernia when using prophylactic meshes, it may lead to new recommendations for this patient group.
PHaLIR is a prospective, double-blinded randomized study in which patients planned for stoma reversal after rectal cancer surgery will be randomized to retro muscular mesh Ultrapro Advanced or standard treatment without mesh. Operating time, complications, LOS, pain, infections and postoperative hernia are to be studied. The patients will be identified and asked about participation when they come for postoperative control after rectal cancer operation and are planned for the ileostomy reversal after check of the rectal anastomosis. They will be given oral and written information and signed informed consent is required from all patients.
At operation the operation-protocol should be filled in. The operation notes will be written in a blinded way and the original version will be stored on paper until after the study is finished and then added to the patient chart.
At discharge from the surgical ward the patient should be planned for a follow up at the surgical clinic at 30 days postoperatively. The doctor at the follow up visit should be another than the operating surgeon. The patients should then fill in a questionnaire and the surgeon should note the postoperative complications in the 30-days follow up form. At the 30-day follow up the surgeon checks that the one-year follow up after the cancer operation is commissioned. Normally this is a CT thorax and abdomen with contrast. For the study-patients it should be complemented with the question of hernia and the CT scan shall be a CT with straining. The normal 1-year follow up for the cancer will be the follow up for the ileostomy reversal also. That means that in most cases it will take place 6-9 months after the reversal. At this control and at the three years control (after cancer operation) the patient will be given or mailed a questionnaire (the same as the 30-day questionnaire). The follow up by doctor could be done either with a clinical visit or a telephone call according to the routines of the clinic when they follow up their cancer patients. At three years follow up after cancer operation patients will also get the same questionnaire and the CT scan follow up at three years will also be with straining.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Loop Ileostomy
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2, Phase 3
Interventional Study Model
Parallel Assignment
Model Description
Randomized controlled trial
Masking
ParticipantOutcomes Assessor
Masking Description
The patient and the surgeon performing the follow-up are masked for the allocation
Allocation
Randomized
Enrollment
208 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Mesh reinforcement
Arm Type
Experimental
Arm Description
Retro muscular mesh at the stoma site.
Arm Title
No reinforcement
Arm Type
Placebo Comparator
Arm Description
Standard closure of the abdominal wall
Intervention Type
Combination Product
Intervention Name(s)
Mesh reinforcement
Intervention Description
Reinforcement of the abdominal wall with Ultrapro Advanced.
Intervention Type
Other
Intervention Name(s)
No reinforcement
Intervention Description
Suturing the abdominal wall without mesh reinforcement
Primary Outcome Measure Information:
Title
Hernia
Description
Hernia at the site of the stomal closure
Time Frame
One year
Secondary Outcome Measure Information:
Title
Operation time
Description
Total operation time
Time Frame
Three hours
Title
Time for closing the stoma site
Description
Time required to close the stoma site
Time Frame
One hour
Title
Hospital stay
Description
Days to discharge
Time Frame
Seven days
Title
Postoperative pain
Description
Pain assessed on a Visual analogue scale ranging from 0 to 100, without subscales. 0 corresponds to no pain and 100 the most intense pain sensation imaginable.
Time Frame
Thirty days
Title
Postoperative complications
Description
Complications, including surgical site infections
Time Frame
Thirty days
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients operated for low anterior resection for rectal cancer with a diverting loop ileostomy and planned for stoma reversal
Exclusion Criteria:
Language barrier or cognitive disability
Recurrent cancer
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Åsa Hallqvist Everhov, MD, PhD
Phone
+46702264127
Email
asa.hallqvist-everhov@sll.se
First Name & Middle Initial & Last Name or Official Title & Degree
Jonas Nygren, MD, PhD
Email
Jonas.Nygren@erstadiakoni.se
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Åsa Hallqvist Everhov, MS, PhD
Organizational Affiliation
Stockholm South General Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Stockholm South General Hospital
City
Stockholm
ZIP/Postal Code
11883
Country
Sweden
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Karolina Eklöf, MD
Facility Name
Ersta Hospital
City
Stockholm
Country
Sweden
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jonas Nygren, MD, PhD
Facility Name
Södertälje Hospital
City
Södertälje
Country
Sweden
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sven Bringman
Facility Name
Västmanland Hospital
City
Västerås
Country
Sweden
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Abbas Chabok, MD PhD
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Prevention of Hernia After Loop Ileostomy Reversal
We'll reach out to this number within 24 hrs